Serious adverse effects have not shown up in the research literature
10.2337/diabetes.50.8.1844 31
Chang HT, Olson LK, Schwartz KA
Semaglutide and other GLP-1 receptor agonists have transformed weight loss treatment, but patients with ulcerative colitis or Crohn's disease face unique decisions
In conclusion, the aforementioned research indicates that PCs can mitigate oxidative stress associated with aging skin by neutralizing ROS accumulation, suppressing lipid peroxidation caused by ROS, and enhancing overall antioxidant capacity, as shown in Table 2
Emerging Therapies and Expanding Potential The research agenda just outlined assumes a relatively stable therapeutic landscape, one in which the primary task is generating better evidence for the combinations already in use